ResMed
528 hedge funds and large institutions have $13.1B invested in ResMed in 2019 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 187 increasing their positions, 178 reducing their positions, and 27 closing their positions.
163% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 27
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
36% more call options, than puts
Call options by funds: $55.2M | Put options by funds: $40.7M
11% more capital invested
Capital invested by funds: $11.8B → $13.1B (+$1.27B)
9% more funds holding
Funds holding: 485 → 528 (+43)
5% more repeat investments, than reductions
Existing positions increased: 187 | Existing positions reduced: 178
0.03% less ownership
Funds ownership: 67.49% → 67.46% (-0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
+$59.1M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$58M |
| 3 |
BlackRock
New York
|
+$47.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.9M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$24.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$65.7M |
| 2 |
Los Angeles Capital Management
Los Angeles,
California
|
-$52.9M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$51.5M |
| 4 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
-$46.1M |
| 5 |
PP
Prudential plc
London, England,
United Kingdom
|
-$27.6M |
RMD Hedge Fund Activity: Q3 2019 in Review
528 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q3 2019, worth a combined $13.1B — up 11% from $11.8B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new RMD positions and 27 closed out — a net gain of 44 holders — while 187 added to existing stakes and 178 trimmed.
The largest buyer was WCM Investment Management, adding an estimated $59.1M. The largest seller was Amundi Asset Management US, cutting an estimated $65.7M.
- 528 institutional investors held ResMed (RMD) as of Q3 2019, up from 485 in Q2 2019.
- Funds reported $13.1B of ResMed stock for Q3 2019, up 11% quarter-over-quarter.
- 71 funds opened new ResMed positions in Q3 2019 and 27 closed out, a net change of +44 holders.
- The largest ResMed buyer in Q3 2019 was WCM Investment Management, an estimated $59.1M added.
- The largest ResMed seller in Q3 2019 was Amundi Asset Management US, an estimated $65.7M sold.
Based on aggregated 13F filings for Q3 2019.